Abstract
Small non-coding regulatory RNAs (sRNAs) post-transcriptionally affect multiple phenotypes in prokaryotes and eukaryotes, yet most of the underlying regulatory mechanisms and the nature of the target mRNAs remain unclear. Here we report the identification and functional analysis of the novel cis-encoded sRNA h2cR, from the human opportunistic pathogen Burkholderia cenocepacia J2315. The sRNA was found to negatively regulate the hfq2 mRNA, through binding to part of the 5′-UTR region of the hfq2 mRNA, resulting in accelerated hfq2 mRNA decay and reduced protein levels in exponentially growing cells. Both the h2cR transcript and the hfq2 mRNA are stabilized by the other B. cenocepacia RNA chaperone, Hfq. Infection experiments using the nematode Caenorhabditis elegans revealed that down-regulation of Hfq2 by h2cR decreases the B. cenocepacia ability to colonize and persist within the nematode, suggesting a role for h2cR on bacterial persistence in the host.
Introduction
Small RNAs (sRNAs) post-transcriptionally regulate multiple phenotypic traits in prokaryotes and eukaryotes. In bacteria, sRNAs have been implicated in the response to environmental stress [1], [2] and, more recently, in the regulation of virulence [3]–[8]. Bacterial sRNAs can be classified as cis-encoded sRNAs, with extended complementarity to their target mRNA and located in the same DNA region, and trans-encoded sRNAs which only partially hybridize with their mRNA target, being encoded in distinct loci from it [9]. Most of the known bacterial sRNAs require the action of the RNA chaperone Hfq to promote interaction with their targets [10]. The Hfq RNA chaperone has been shown to facilitate sRNAs/mRNAs transactions by stimulating RNA duplex formation between sRNAs and their mRNA targets [11]–[13]. Although most of the known Hfq proteins are required sRNAs/mRNAs interactions, in the case of S. aureus, sRNA/mRNA interactions seem to proceed without the requirement of Hfq [14]. However, hfq regulation itself is only incompletely understood, particularly in organisms which contain more than one Hfq protein, as it is the case of bacteria of the Burkholderia cepacia complex, composed of opportunistic human pathogens [15]–[18].
The soil bacterium Burkholderia cenocepacia harbors two distinct Hfq-like proteins, Hfq and Hfq2 [19], which are differentially expressed during cell growth: hfq mRNA reaches maximal levels in the early exponential growth phase, while hfq2 mRNA is maximally expressed in the stationary phase [20]. Factor(s) involved in quorum sensing in B. cenocepacia have been implicated in the up-regulation of Hfq2 during the stationary phase [20]. Here we report on the identification of the novel sRNA h2cR which is actively transcribed during exponential growth of B. cenocepacia J2315. Data presented indicate that h2cR negatively regulates hfq2 mRNA by interacting with its 5′-UTR. Results obtained upon silencing h2cR in B. cenocepacia J2315 indicate a reduced ability of the opportunistic pathogen to colonize the Caenorhabditis elegans used as a infection model, implicating this sRNA in the persistence of the bacterium at least in this particular host.
Materials and Methods
Bacterial strains and culture conditions
B. cenocepacia strains used in this work (Table 1) were maintained on PIA plates (Pseudomonas Isolation Agar, Becton Dickinson, New Jersey, USA), supplemented with 850 µg ml−1 trimethoprim or 350 µg ml−1 chloramphenicol or kanamycin, when appropriate. LB medium, supplemented with antibiotics when appropriate, was used for liquid cultures which were orbitally agitated (250 rev min−1, 37°C) using an Agitorb 200 incubator (Aralab, Portugal).
Table 1. Bacterial strains and plasmids used in this work.
Strain | Description | Reference or source |
B. cenocepacia J2315 | CF sputum isolate | [44] |
B. cenocepacia CJ1 | B. cenocepacia J2315 derivative with the hfq gene interrupted by a Tp gene cassette | [20] |
B. cenocepacia CJ2 | B. cenocepacia J2315 derivative with the hfq2 gene interrupted by a non-sense stop mutation | [20] |
B. cenocepacia J2315+ pSAS3 | B. cenocepacia J2315 harbouring plasmid pSAS3 | [20] |
B. cenocepacia CJ1+ pSAS3 | B. cenocepacia CJ1 mutant harbouring plasmid pSAS3 | [20] |
B. cenocepacia CJ4 | B. cenocepacia J2315 harbouring plasmid pCGR17 | This study |
B. cenocepacia CJ5 | B. cenocepacia J2315 harbouring plasmid pCGR18 | This study |
B. cenocepacia CJ6 | B. cenocepacia CJ2 mutant harbouring plasmid pCGR27 | This study |
B. cenocepacia CJ7 | B. cenocepacia CJ4 harbouring plasmid pCGR27 | This study |
B. cenocepacia CJ8 | B. cenocepacia CJ5 harbouring plasmid pCGR27 | This study |
B. cenocepacia CJ9 | B. cenocepacia J2315 harbouring plasmid pCGR31 | This study |
B. cenocepacia CJ10 | B. cenocepacia J2315 harbouring plasmid pCGR32 | This study |
B. cenocepacia CJ11 | B. cenocepacia J2315 harbouring plasmid pMLBAD | This study |
B. cenocepacia CJ12 | B. cenocepacia J2315 harbouring plasmid pBBR1 | This study |
E. coli BL21 | Host for recombinant protein expression | Stratagene |
E. coli TOP10 F' | Host for recombinant plasmids | Invitrogen |
Plasmids | ||
pCR II | ApR; KmR; TOPO-TA cloning plasmid | Invitrogen |
pET23a+ | ApR, used for C-terminal 6×histidine-tagged protein expression. | Stratagene |
pMLBAD | TmpR; used for gene expression in Bcc | [45] |
pBBR1MCS | CmR; used for gene expression in Bcc | [46] |
pSAS5 | pWH884 with the hfq2 gene cloned | [20] |
pSAS6 | pET23a+ with the ompA gene clone | (Sousa, SA, Leitão JH) Unpublished data |
pSAS3 (phfq) | pMLBAD with the hfq gene cloned | [21] |
pCGR4 | pET23a+ with the hfq gene | [21] |
pCGR10 | pCR II with the 136 bp cDNA fragment of the h2cR sRNA TA-cloned | This study |
pCGR11 | pCR II with the 668 bp cDNA fragment of the hfq2 mRNA TA-cloned | This study |
pCGR12 | pCR II with the 216 bp cDNA fragment of the 5′UTR hfq2 RNA TA-cloned | This study |
pCGR13 | pCR II with the 216 bp cDNA fragment of the5′UTR hfq2 RNA cloned in the HindIII/BamHI sites (T7 promoter control) | This study |
pCGR14 | pCR II with the 136 bp cDNA fragment of the h2cR RNA cloned in the HindIII/BamHI sites (T7 promoter control) | This study |
pCGR17 (ph2cR) | pMLBAD with the 136 bp cDNA fragment of the h2cR RNA cloned in the XbaI/HindIII sites | This study |
pCGR18 (h2cRsil) | pMLBAD with the 104 bp anti sense cDNA fragment of the h2cR with a cca extension cloned in the EcoRI/XbaI sites | This study |
pCGR26 | pCGR13 with the his-tagged Hfq2 cloned in the HindIII/EcoRI sites | This study |
pCGR27 (pThfq2) | pBBR1MCS with the N-terminus 6xhistidine tagged hfq2 and its complete 5′UTR cloned in the XhoI/HindIII sites | This study |
pCGR28 | pCR II with the 180 bp cDNA fragment of the −220 to −40 region of hfq2 5′UTR cloned in the XbaI/HindIII sites | This study |
pCGR29 | pCR II with the 100 bp cDNA fragment of the −70 to +30 region of hfq2 5′UTR cloned in the XhoI/BamHI sites | This study |
pCGR30 | pCR II with the250 bp cDNA fragment of the −220 to +30 region of hfq2 5′UTR cloned in the XbaI/NotI sites | This study |
pCGR31 | pBBR1 with the 136 bp cDNA fragment of the h2cR RNA cloned in the XbaI/HindIII sites | This study |
pCGR32 | pBBR1 with the 104 bp anti sense cDNA fragment of the h2cR with a cca extension cloned in the EcoRI/XbaI sites | This study |
DNA manipulation techniques
Total DNA was obtained from exponentially growing cells of B. cenocepacia J2315 using the High pure PCR template preparation kit (Roche, Indianapolis, USA). Plasmids used in this work are described in Table 1 and oligonucleotides are listed in Table 2. Amplification of B. cenocepacia J2315 hfq2, hfq2 5′-UTR, and h2cR was achieved with adequate primers (Table 2). PCR products were purified from 0.8 % agarose gels, after electrophoresis, using the NucleoExtract II kit (Machery-Nagel, Hannover, Germany), and were used for plasmid construction either by TA-cloning of the DNA fragments or by ligation of endonuclease-digested PCR fragments to the corresponding linearized plasmid. Resulting plasmids were used in PCR experiments with adequate primer combinations (M13 reverse primer and the appropriate upper primer) to confirm the correct orientation of the cloned DNA fragment. Plasmids pCGR11 (hfq2 mRNA), pCGR13 (hfq2 5′-UTR), pCGR14 (h2cR sRNA), pCGR28 (nt −220 to −40 of hfq2 5′-UTR), pCGR29 (nt −70 to +30 of hfq2 5′-UTR) and pCGR30 (nt −220 to +30 of hfq2 5′-UTR) were used for in vitro transcription experiments. Silencing of the h2cR sRNA was achieved by expressing a truncated (104 nt) anti-sense h2cR RNA derivative, containing a 3′ proximal CCA extension. Plasmid pCGR26 was constructed by cloning the HindIII/EcoRI fragment of plasmid pSAS5 [20] containing the hfq2 gene fused with a six-histidine tag at the N-terminus, into the HindIII/EcoRI sites of pCGR13. Plasmid pCGR27 was constructed by cloning the fragment obtained from restriction of pCGR26 with XhoI/HindIII into the XhoI/HindIII sites of pBBR1MCS, allowing the expression and translation of the His-tagged Hfq2 from its own promoters. pBBR1MCS and derivatives are fully compatible with pMLBAD [18], [19]. Plasmid pCGR31 (+h2cR) was constructed by sub-cloning the XbaI-HindIII fragment obtained from pCGR14 into the XbaI-HindIII sites of pBBR1MCS, while pCGR32 (h2cRsil) was constructed by cloning the EcoRI-XbaI fragment obtained from pCGR14 into the EcoRI-XbaI sites of pBBR1MCS. These plasmids allow the constitutive expression of the cloned genes in B. cenocepacia (Ramos, da Costa and Leitão, unpublished results). All plasmid constructions were confirmed by DNA sequencing.
Table 2. Oligonucleotides and primers used in this work.
Name | Sequence (5′–3′) | Purpose | Reference or source |
M13 Fwd M13 Rev | CTGGCCGTCGTTTTAC CAGGAAACAGCTATGAC | PCR screening of clones and transcription template Northern analysis of hfq Northern analysis of hfq2 Northern analysis of 5S rRNA | Invitrogen Invitrogen [20] |
HFQ | AAAGGGCAATTGTTACAAG | ||
HFQ2 | TACGGCTCCCGCGAGCCGCGTGAA | [20] | |
5S | TTCGGGATGGGAAGGGGTGGGA | [20] | |
NBh2c | TTACGGTTCGACACAATCAC | Northern blot analysis of h2cR | This study |
T7-TSS-H2 | ATACGGGGCTGCGAGTCGT | In vitro transcription of the of hfq2 mRNA In vitro transcription of the of hfq2 mRNA | This study |
Hfq2c_Rev | TTGTCGACTTACTGGCCGTCCGGCAC | [20] | |
5H2-H | TTAAGCTTGCCTCTTGTTCATGCTCC | In vitro transcription of the 5′UTR of hfq2 In vitro transcription of the 5′UTR of hfq2 | This study |
5H2-B | TTGGATCCTGAGGTGCGGCAGGAGCC | This study | |
h2cR-H | TTTTAAGCTGCGTCAGAGAAT | In vitro transcription of the h2cR sRNA In vitro transcription of the h2cR sRNA | This study |
h2cR-B | TTGGATCCGCGAAAATGCGCC | This study | |
h2cR-X | TTTCTAGAGTGCGTCAGAGAAT | Overexpression of h2cR | This study |
h2cR-H2 | TTAAGCTTGCGAAAATGCGCC | Overexpression of h2cR | This study |
h2cR-E | TTGAATTCTGCGTCAGAGAAT | Silencing of h2cR | This study |
h2cR-Xcca | TTCTAGAGTTCAAAATGCGCC | Silencing of h2cR | This study |
CGRO100 | TTTTCTAGACCGTTCTATATTGACGG | Amplification of the −220 region | This study |
CGRO101 | TTAAGCTTTTGCTGAAGTTGTTCGGT | Amplification of the −40 region | This study |
CGRO103 | TTCTCGAGTGATTGTGTCGAACCGTA | Amplification of the −70 region | This study |
CGRO104 | TTGGATCCTGCGGATGGGATTCTGCGGG | Amplification of the +30 region | This study |
5′ RACE Adapter | 5′-GCUGAUGGCGAUGAAUGAACACUGC GUUUGCUGGCUUUGAUGAAA-3′ | 5′ RACE h2cR | Ambion |
5′ RACE Outer Primer | 5′-GCTGATGGCGATGAATGAACACTG-3′ | 5′ RACE h2cR | Ambion |
5′ RACE Inner Primer | 5′-CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATG-3′ | 5′ RACE h2cR | Ambion |
5′R | 5′-AATCACGACTGCGCGCTCCC-3′ | 5′ RACE h2cR | This study |
Northern blot analysis
The levels of transcripts corresponding to hfq2 mRNA or h2cR sRNA were assessed by Northern blot analysis using 2 µg of total RNA purified from cells of B. cenocepacia J2315 and derivative strains. Total RNA was loaded into 6 or 15 % and 8 M urea polyacrylamide gels for hfq2 and h2cR respectively, and electrophoresed in 1× TBE buffer at 35 mA. After electrophoresis, total RNA was electrotransferred at 20 V, for 16 h at 4°C using 0.5× TBE buffer to a BrightStar Plus membrane (Ambion, Madrid, Spain). Oligonucleotide probes (Table 2) were labeled with the BrightStar Biodetect kit (Ambion) and purified using Quick-Spin columns (Roche). Pre-hybridization and hybridization procedures were based on previously described methods [20]. The 5S rRNA was used as control in all Northern blot analysis experiments. Hybridization signals were detected using the BrightStar Biodetect kit (Ambion) and Kodak MX X-ray films. Relative expression analysis was estimated using the ImageJ software and the band intensities of the 5S rRNA as standard.
RNA levels and decay experiments
Total RNA was obtained from cells of B. cenocepacia J2315 and derivative strains using the Ribopure RNA isolation kit (Ambion) or the mirVana miRNA isolation kit (Ambion), for total RNA or sRNA-enriched fractions, respectively. RNA concentration was estimated in a ND 1000 spectrophotometer (Nanodrop). RNA labeling with biotin was conducted as previously described [20], [21]. In RNA decay experiments, 500 µg.mL−1 of rifampicin were added, immediately before the assay, to cell cultures at 24 h of growth for hfq2 assays or at 2 h, 8 h or 24 h for h2cR assays. 2 µg of total RNA were used in each experiment. Films were scanned and the intensity of RNA bands was measured with the ImageJ software. The intensities were plotted in semi-log plots and RNA half-life was calculated using the slope of each plot.
Electrophoretic mobility shift (EMSA) assays
EMSA assays with the h2cR transcript, the hfq2 coding region, the hfq2 full mRNA and the 5′-UTR of the hfq2 transcript and derivatives were performed as previously described [20]. The His-tagged Hfq protein used in EMSA assays was prepared as previously described [21]. Briefly, for EMSA assays, 2.5 nM of the h2cR, together with 0, 0.1, 0.5 or 2.5 nM of the hfq2 full transcript or the hfq2 coding sequence, or increasing amounts of the hfq2 5′UTR derivatives (0, 0.1, 0.5, 2.5 or 10 mM) were incubated in 25 µl of RNA binding buffer [21] for 30 min at 25°C. The ability of Hfq to bind h2cR (2.5 nM) or hfq2 5′-UTR (2.5 nM), was evaluated by EMSA assays using 0, 0.5, 1, 5 or 10 nM of the hexameric form of His-tagged Hfq (Hfq6), or 0, 0.5, 1, 5, 10 or 50 nM of His-tagged Hfq6, respectively. Non-labelled yeast tRNA (Ambion) was added in excess to each sample to minimize non-specific binding. Incubation, resolution of RNA-protein complexes and detection of band-shifts was performed as described before [21].
RNA in vitro transcription and labeling
The cDNA templates for the hfq2 mRNA full transcript, the hfq2 5′-UTR, the hfq2 coding region (CDS), the nt −220 to −40 (Start), the nt −70 to +30 (Mid) and nt −220 to +30 (End) 5′-UTR, or the h2cR sRNA, were generated by PCR, using the following primer pairs and DNA templates: T7-TSS-hfq2– hfq2Low, and plasmid pCGR11; 5H2-H –5H2-B, and plasmid pCGR12; Up_hfq2_C – Low_hfq2_C, and plasmid pCGR8; CGRO100– CGRO101, and plasmid pCGR28; CGRO102– CGRO103, and plasmid pCGR29; CGRO100– CGRO103, and plasmid pCGR30, or h2cR-X – h2cR-H2, and plasmid pCGR14. All RNA transcripts were generated from the T7 promoter, using the MEGAshortscript kit (Ambion). The transcripts h2cR (136 nt), 5′-UTR (216 nt), Start (180 nt), Mid (100 nt), and End (250 nt) were purified from 8%−7 M urea polyacrylamide gels, while the hfq2 derivatives CDS (585 nt) and the full transcript (801 nt) where purified from a 1% TBE/agarose gel. RNAs were subsequently ethanol-precipitated and 5′ end-labelled with 11-UTP-biotin (Ambion). RNA 5′end-labelling was achieved after dephosphorylation with 2 U of calf intestinal phosphatase (New England Biolabs, NEB, Ipswich, USA) for 15 min in NEB buffer 2, with T4 polynucleotide kinase (PNK, NEB). Briefly, 200 pmol of RNA were mixed with 7.5 nmol of 11-UTP-Biotin, in a total volume of 50 µl, containing 1 mM ATP, 5 µl of 10× T4 PNK buffer, and 10 U of T4 PNK. Reactions were carried out at 37°C for 30 min. RNA was phenol-chloroform extracted, ethanol precipitated, and finally cleaned-up with Ilustra NAP-5 columns (GE Healthcare, Pollards Wood, UK).
Rapid amplification of 5′ ends of cDNA (5′RACE)
Amplification of the cDNA end corresponding to the h2cR sRNA was achieved by using total RNA purified from B. cenocepacia J2315 cells in the early exponential phase (2 h), exponential phase (8 h) or in the stationary phase (24 h). RNA was isolated from cells using the mirVana kit (Ambion) for h2cR, followed by DNase I treatment with TurboDNase (Ambion). Amplification of the 5′-end of cDNA was carried out using the First Choice RLM Race kit (Ambion), using 20 pmol of the primer 5′R (5′RACE of h2cR) (Table 2) and 5 µg of total RNA. Amplification products were fractionated in 1% agarose gels and 7.5% PAGE, and visualized after Sybr Gold Staining (Invitrogen Madrid, Spain). Amplification fragments were purified from the gel with the Nucleospin II kit (Macherey-Nagel), and used for cloning into plasmid pCR II-TOPO. Resulting plasmids were used to transform E. coli Top10 F'. Plasmids from selected clones were sequenced.
Determination of Hfq2 levels
The effect of the h2cR sRNA on the levels of the Hfq2 protein was assessed by western blotting. For this purpose, plasmid pCGR27 (pThfq2), which is able to drive the transcription of hfq2 fused with a nucleotide sequence encoding a six histidine tag at the N-terminus from each of the hfq2 own promoters, was introduced into B. cenocepacia CJ2 (Δhfq2), yielding B. cenocepacia CJ6. The CJ6 strain was further transformed with plasmids pCGR17 or pCGR18, which allow the h2cR overexpression (strain CJ8) or silencing (strain CJ7), respectively. The cultures were grown for 24 h in liquid LB, supplemented with 650 µg ml−1 trimethoprim and 1% L-arabinose. Culture aliquots of 1 ml were taken, the protein was purified with the Illustra TriplePrep kit (GE Healthcare), and ressuspended in 100 µl of 2D-DIGE buffer (30 mM Tris-HCl, 4% CHAPS, 2 M thiourea, 7 M urea, pH 8.5). Protein concentration was estimated in a Nanodrop 1000 spectrophotometer. Aliquots containing 20 µg of total protein were separated by 12% SDS-PAGE and then electroblotted onto a nitrocellulose membrane, using Towbin transfer buffer, for 45 min at 120 mA. The 6xHis-tagged Hfq2 protein was detected using the PentaHis-HRP antibody system (Qiagen Madrid, Spain) with tetramethylbenzidine (Sigma, St. Louis, USA) as substrate.
Nematode infection experiments
Nematode killing assays and bacterial colonization of the digestive tract of the nematodes were performed based on previously described methods [21], using the C. elegans mutant strain DH26, cultured in NGM II medium, supplemented with 2% L-arabinose, when appropriate. Total protein and RNA were also obtained from B. cenocepacia strains CJ6, CJ7 and CJ8, when infecting the nematode C. elegans. Worms were lysed using silica-carbide beads (Biospec Products Inc, USA), based on previously described methods [22]. Total bacterial RNA was obtained from total RNA after purification with the Microbe-Enrich kit (Ambion), following the manufacturer instructions. After clean-up of the bacterial total RNA with the mirVana kit (Ambion), aliquots were used for Northern blot analysis experiments to assess the levels of the hfq2 mRNA, the h2cR transcript, and the 5S rRNA. Total protein was obtained with the Illustra TriplePrep kit (GE Healthcare), and processed as described above. Protein aliquots were used to assess the Hfq2 levels by western blot, as described above.
Bioinformatics
BLAST searches were performed using the Integrated Microbial Genomes (IMG) webserver (E-value ≤ 1e−50). The h2cR sRNA secondary structure was predicted using the Mfold algorithm [23], and modeled with the RNA structure program (v5.03). Alignment of h2cR and the 5′-UTR of hfq2 was achieved using the RNAHybrid software [24]. Putative promoter were predicted using the Virtual Footprint and PRODORIC web tool [25].
Statistics
An unpaired two-tailed-chi test was used to calculate the P values for the Western blotting experiments and the C. elegans assays. Analysis of data from Northern blotting was performed using a paired one-tailed t test to calculate the P values (***, P<0.001; **, P<0.005; *, P<0.01). Error bars represent the means of the standard deviation. Variance was computed based on ANOVA analysis. Images shown are representative of each the experiments repetitions performed. All experiments were repeated independently at least 4 times, using triplicates, with a minimum of n = 12.
Results
Identification and cloning of h2cR
To identify sRNAs from B. cenocepacia which may interact with the RNA chaperone Hfq, we have co-purified the His-tagged Hfq protein together with B. cenocepacia sRNA fractions (<200 nt) [20], [21], followed by sequence analysis of the cloned cDNA fragments. This experimental approach allowed the identification of a novel sRNA, named h2cR (Hfq2 cis regulatory RNA), which was cloned into the pCR II cloning vector, yielding pCGR10. In silico analysis of B. cenocepacia J2315 chromosome 1 revealed that the h2cR encoding sequence ranged from nt 1704623 to 1704759 in the reverse strand of the 5′-untranslated region (UTR) sequence of hfq2 (Fig. 1A). A putative promoter sequence upstream of the h2cR predicted transcription start site was bioinformatically identified (Fig. 1A), although the predicted −35 (gaTTGAGAgc) and −10 (aaTTAATAAcg) boxes consensus sequences found were highly degenerated. The h2cR secondary structure was predicted to be composed of a duplex, with an energy of −48.7 kCal/mol, with a 5′ overhang of 5 nucleotides (5′-gucag) and a 3′-terminal poly-U (Fig. 1B).
Bioinformatic analyses revealed the presence of h2cR homologues among all members of the Bcc, with an identity of at least 85%. h2cR homologues were also found among other Burkholderia species, with an identity of at least 75%. Remarkably, no h2cR homologues were found in other bacterial genomes (data not shown).
In order to analyze the pattern of h2cR transcript accumulation in cells at different growth phases, cultures of the B. cenocepacia J2315 (wt) strain were carried out in liquid LB at 37°C, and total RNA was extracted and used in Northern blot experiments. Results obtained showed that h2cR transcripts were maximal in cells at the early exponential phase of growth, decreasing to undetectable levels in cells at the stationary phase (Fig. 1C) in a pattern opposite to that previously described for the hfq2 mRNA [18]. To determine the transcription start and stop sites of the h2cR sRNA, we have performed 5′-RACE experiments, followed by cloning and sequencing of the resulting cDNA amplimers. A major band of ∼75 bp was obtained with RNA samples from cultures grown for 2 h, 8 h or 24 h (Fig. 1D). Sequence determination allowed us to locate the h2cR Transcription Start Site (TSS) at nucleotide position 1704623 in B. cenocepacia J2315 chromosome 1.
h2cR affects hfq2 mRNA levels
Since most known cis-encoded sRNAs exert their regulatory action on adjacent genes [9], hfq2 was investigated as a possible mRNA target of h2cR, by means of over-expressing or silencing the sRNA. For this purpose, the wt strain was transformed with plasmid pCGR18, expressing a 104-nt anti-sense RNA that silences h2cR upon induction with arabinose. The resulting strain, CJ5, is hereafter referred as h2cRsil. The wt strain was also transformed with plasmid pCGR17 which overexpresses h2cR upon arabinose induction (wt+ph2cR). We have also included in these analyses a B. cenocepacia J2315 hfq mutant (strain CJ1) [20] and derivatives which either overexpress or silence h2cR, to assess any possible role played by Hfq on h2cR levels and/or stability. In the wt strain, as well as in the hfq mutant (Δhfq), hfq2 mRNA levels increased over time, reaching maximal values in cells at the stationary phase, with hfq2 mRNA levels being higher in the wt strain than in the Δhfq strain (Fig. 2A). Overexpression of h2cR in both the wt (wt+ph2cR) and the Δhfq (Δhfq+ph2cR) strains led to almost undetectable levels of hfq2 mRNA during the exponential growth phase and high hfq2 mRNA levels in cells at the stationary phase. In contrast, the silencing of h2cR led to higher hfq2 mRNA levels during exponential phase in both the wt (h2cRsil) and the Δhfq (Δhfq+h2cRsil) strains (Fig. 2A). Interestingly, overexpression of hfq led to increased amounts of hfq2 mRNA in both strains (wt+phfq and Δhfq+phfq) during the exponential phase of growth, suggesting a possible role for Hfq in hfq2 mRNA expression/stability. The results obtained when assessing the half-life of the hfq2 mRNA on the different genetic backgrounds indicate that silencing of h2cR in the wt strain increased the hfq2 mRNA half-life time to ∼30%, while overexpression of h2cR had almost no impact on the hfq2 mRNA half-life time (reduction of only ∼6%) (Fig. 2A right panel). Interestingly, the hfq2 mRNA half-life was also reduced in the hfq mutant, by approximately 25% (Fig. 2A). Taken together, these results indicate that h2cR negatively affects hfq2 mRNA levels. In addition, results also suggest that Hfq plays a role in the stability of the h2cR transcript and the hfq2 mRNA.
We have also assessed the levels of h2cR in the same strains used to assess the hfq2 mRNA levels. The h2cR transcript levels were maximal in the early exponential growth phase in both the wt and the Δhfq strains (Fig. 2B). In both strains, silencing of h2cR led to almost undetectable levels of h2cR transcripts in the exponential phase and to only barely detectable h2cR levels in the stationary phase. Contrasting with the observed h2cR transcripts accumulation throughout the exponential and stationary phase in the wt strain overexpressing h2cR, the corresponding RNA levels were surprisingly low in the hfq mutant strain overexpressing h2cR (Fig. 2B). Important differences were also observed in h2cR half-life. Values ranging from 11–14 min were estimated for h2cR in the wt strain and in the wt strain overexpressing h2cR, hfq or hfq2 (Fig. 2B). However, in the hfq mutant and the hfq mutant overexpressing h2cR, the half-lives were reduced to 7–9 min. Taken together, our data strongly suggest that h2cR exerts a negative regulatory effect on hfq2 mRNA, since higher h2cR levels correlate with lower or even absent levels of hfq2 mRNA. A 43% and 25% reduction in h2cR sRNA and hfq2 mRNA half-lives, respectively, were calculated for the Δhfq strain, compared to the wt strain. Complementation of this mutation, using a hfq containing plasmid, partially restored the h2cR half-life to a value of ∼75% of that registered for the sRNA half-life in the wt strain, again suggesting that Hfq somehow stabilizes the h2cR sRNA.
h2cR affects Hfq2 protein levels
The effects of h2cR silencing or overexpression on the levels of the Hfq2 protein produced were also assessed. For this purpose, the B. cenocepacia CJ2 mutant [20], in which the hfq2 gene was deleted (Δhfq2), was transformed with plasmid pCGR27 (expressing a 6 histidine-tagged hfq2 mRNA from the hfq2 own promoters), yielding strain CJ6. This strain allows the assessment of the levels of Hfq2 protein produced by Western blot using an antibody specific for the histidine-tag of the synthesized Hfq2 (see Materials and Methods). The CJ6 strain was further transformed with plasmids that allow h2cR overexpression or silencing, thus enabling the assessment of the effects of h2cR overexpression or silencing on the levels of the Hfq2 protein and the hfq2 mRNA. CJ7 is a CJ6 derivative expressing an h2cR antisense transcript from plasmid pCGR18. CJ8 is a CJ6 derivative overexpressing h2cR from plasmid pCGR17. In the CJ6 strain, the levels of Hfq2 were lower in cells in the exponential phase of growth (2 and 4 h of growth), increasing to double the levels observed in cells at the stationary phase of growth (Fig. 3). The pattern of accumulation of hfq2 mRNA in the CJ6 strain was similar to that observed for the protein Hfq2, although the levels increased by a 3.6 fold. For the CJ8 strain, the levels of the Hfq2 protein were barely detectable in cells after 2 h of growth and its levels increased by 11.5-fold in cells at grown for 24 hours (Fig. 3). Altogether, these results indicate that the levels of Hfq2 are negatively affected by h2cR, in good agreement with the already observed negative effect exerted by h2cR on the hfq2 mRNA stability.
h2cR regulates hfq2 mRNA through binding within its 5′-UTR
In order to gain further insights on the interaction of h2cR and the hfq2 mRNA, we performed electrophoretic mobility shift assays (EMSA) to investigate the formation of complexes between the h2cR sRNA and the hfq2 mRNA. Incubation of biotin-labeled h2cR with increasing concentrations of the complete hfq2 mRNA (hfq2 full, including the 5′-UTR) resulted in the formation of a slower migrating complex, consistent with an interaction between the two RNA molecules (Fig. 4A). In contrast, no complex was observed when the hfq2 coding sequence (hfq2 CDS) was incubated with the biotin-labeled h2cR, indicating that the 5′-UTR of hfq2 is required for the RNA duplex formation (Fig. 4B). Therefore, additional EMSA assays were performed with the biotin-labelled h2cR sRNA, and three derivatives of the hfq2 5′-UTR: one RNA molecule spanning nt −220 to +30 (corresponding to the full 5′-UTR), a second RNA molecule spanning nt −220 to −40 (including most of the 5′-UTR), and a third RNA molecule spanning nt −70 to +30 (including the AUG region). h2cR formed RNA duplexes with the RNA molecule corresponding to the complete hfq2 5′-UTR (−220 +30) and with the RNA molecule spanning nt −220 to −40 of the hfq2 5′-UTR, but not with the hfq2 mRNA derivative spanning the −70 to +30 of the hfq2 5′-UTR (Fig. 4C), indicating that h2cR and hfq2 mRNA interactions are restricted to the nt region −220 to −40 of the hfq2 5′-UTR.
Next we sought to know whether Hfq forms complexes either with h2cR or with the hfq2 mRNA. The results obtained indicate that Hfq interacts with a ∼6-fold higher binding affinity for h2cR (Kd = 1.5 nM), compared to the binding to the hfq2 mRNA (Kd = 9.5 nM) (Fig. 4D). It is possible that the interaction of Hfq with each of these two RNA molecules contributes to their stabilization, in agreement with previous results showing reduced half-lives of both RNA molecules in an hfq-depleted genetic background (Fig. 2).
Controlled levels of h2cR are required for the efficient colonization of C. elegans
Since sRNAs have been implicated in the regulation of virulence [3]–[8], we investigated the role of h2cR on the ability of B. cenocepacia J2315 to colonize and to kill the nematode C. elegans, previously used by our research group as an infection model [26]. Although extrapolations from non mammalian Bcc infection models to human infections should be used with caution [27], C. elegans has been successfully used to investigate the biology of a number of human pathogens [28].
With this objective, the silencing or over-expression of h2cR in the wt was achieved by transforming the strain with the plasmids pCGR18 or pCGR17, which express the h2cR anti-sense transcript of h2cR or overexpress the h2cR transcript upon induction with arabinose, respectively. Silencing of h2cR increased the survival of the nematodes, suggesting that h2cR affects B. cenocepacia virulence towards the nematodes (Fig. 5A). No significant differences in survival of the nematodes infected with the wt strain or the wt strain over-expressing h2cR were detectable (Fig. 5A). To check if the addition of arabinose by itself might have affected the results observed, we have cloned the h2cR coding sequence and the h2cR antisense sequence in plasmid pBBR1MCS, yielding plasmids pCGR31 and pCGR32, respectively. pBBR1MCS is leaky in Burkholderia strains and allows constitutive expression of the cloned genes from the lac promoter in the absence of IPTG induction (CG Ramos, PJ da Costa and JH Leitão, unpublished results). The B. cenocepacia wt, and the wt strain transformed with pCGR31 or pCGR32 were used in infection experiments similar to those described above. The results obtained were similar to those shown in Fig. 5A, indicating that the addition of arabinose did not influence the results obtained (data not shown).
We have also assessed the effects of h2cR overexpression or silencing on the total number of bacteria thriving inside the worm's digestive tract, using the wt strain and their derivatives transformed with pCGR17 or pCGR18. Silencing of the sRNA led to slight differences on the number of CFU per worm compared to controls (wt and wt transformed with pMLBAD), while h2cR overexpression led to a significant reduction of about one log in the total CFU per worm (Fig. 5B). Despite the reduction of the total CFUs per worm observed for the wt strain overexpressing h2cR, the ability of this strain to kill the nematodes was similar to that of the wt strain (Fig. 5B), suggesting the involvement of h2cR on bacterial survival inside the nematode's digestive tract, possibly by affecting the ability of the bacterium to adhere to the nematode's digestive tract. Previous work on the functional characterization of Hfq2 showed a more important role for this protein in killing the nematodes rather than in the colonization of their digestive tract [20], consistent with the effect here registered when silencing h2cR and thus promoting higher amounts of Hfq2. Furthermore, a hfq2 null mutant still retained the ability to colonize and kill nematodes, a trait most probably derived from the expression of other Hfq- and/or Hfq2-independent virulence factors [20]. The results here presented suggest that the effects of h2cR on the persistence and killing ability of B. cenocepacia towards the nematode might result directly from the regulation exerted by the sRNA on the Hfq2. Nevertheless, our results also suggest that h2cR plays an additional role on the bacterium ability to kill the nematodes (Fig. 5A), besides the effects resulting from the regulation of the hfq2 mRNA and, consequently, of the Hfq2 protein abundance.
h2cR regulates hfq2 mRNA levels in B. cenocepacia during infection
In order to assess the levels of the Hfq2 protein, the hfq2 mRNA, and the h2cR transcript in bacteria while infecting the nematodes, worms were harvested after 2, 8, or 24 h post-infection with the strains CJ6, CJ7 and CJ8, and processed to isolate total RNA and total protein from the bacteria thriving inside the nematodes. Results obtained indicate that the Hfq2 protein levels increased over time in the CJ6 strain (Fig. 6). The h2cR transcript levels decreased by about 5.6-fold in this strain, from maximal values detected at 2 h post-infection to minimal levels detected at 24 h, while the hfq2 mRNA levels increased almost 2-fold over time. Consistent with the results presented in Fig. 3, the h2cR transcript in CJ6 was almost undetectable at the stationary phase. Silencing of h2cR did not change the already observed patterns of variation of the Hfq2 protein and of the hfq2 mRNA (Fig. 6, CJ7 panel). In fact, an increase in the levels of the hfq2 mRNA and Hfq2 protein were detected in the CJ7 strain (Fig. 6, CJ7 panel). For the strain CJ8 overexpressing the sRNA, the levels of the Hfq2 protein and of the hfq2 mRNA showed a pattern of variation similar to that of the CJ6 strain, although both the mRNA and protein levels were highly reduced (Fig. 6, panel CJ8), except in cells grown for 24 h.
Discussion
Recent work from our research group led to the identification of two distinct and functional Hfq-like encoding genes within the genome sequence of the opportunistic human pathogen Burkholderia cenocepacia J2315, as well as in other members of the Burkholderia genus [20], [21]. The exploitation of the ability of Hfq-like proteins to bind RNA molecules allowed us to experimentally identify sRNAs from B. cenocepacia J2315. In this bacterium, as well as in other members of the so-called Burkholderia cepacia complex (Bcc), evidences point out that several sRNAs are encoded within their genomes [29]–[31]. However, no biological functions have been attributed yet to Bcc sRNAs. Our experimental strategy allowed the identification of a sRNA, named h2cR, which is the subject of the present work. The h2cR encoding gene locates in the strand complementary to the strand encoding hfq2, in the opposite direction of transcription, partially overlapping the hfq2 gene. This chromosomal location does not allow the generation of mutants on h2cR without affecting, at least, the functionality of the hfq2 gene. Therefore, our analysis on the possible biological roles of h2cR was based on the sRNA overexpression or silencing.
Data presented indicate that h2cR is a cis-encoded negative regulator of the hfq2 mRNA, exerting its negative regulatory effect by binding to the hfq2 mRNA 5′-UTR region. h2cR was also found to be involved in virulence traits of B. cenocepacia J2315. In fact, results presented show that the sRNA affects the ability of the bacterium to persist inside the nematode's digestive tract. Previous work on the functional characterization of hfq2 indicated a role for the encoded protein in the killing the nematodes and in their persistence in the host digestive tract [20], suggesting that the observed effects are not only due to the negative regulation exerted by h2cR on the levels of hfq2 mRNA and, consequently, of the Hfq2 protein. Examples of sRNAs involved in the virulence of bacteria within their hosts are known. For instance, the Streptococcus pyogenes rivX sRNA plays an important role in virulence, linking the CovR and Mga regulatory networks, enabling the pathogen to select from its repertoire the expression of specific virulence determinants in response to a broad spectrum of environments [32]. However, no homology exists between the B. cenocepacia J2315 h2cR and the S. pyogenes rivX.
To the best of our knowledge, this is the first description of the regulation of an hfq-like gene by a sRNA. Interestingly, the results here presented also show that in the mutant in the other B. cenocepacia J2315 RNA chaperone encoding gene hfq, the half-life of hfq2 mRNA was reduced compared to the wt strain, suggesting a role of the RNA chaperone Hfq on the stabilization of the hfq2 mRNA. The role of Hfq-like proteins in the stabilization of RNA molecules has been described in other bacteria, through the protection of the RNA molecules from RNase E degradation [33]–[35]. Although there is no evidence of the occurrence of similar mechanisms in Burkholderia organisms, RNase E-like encoding genes are anoted in several Burkholderia genomes [36], [37].
Despite the numerous studies on Hfq proteins from distinct bacterial species as global regulators of bacterial metabolism and virulence, only a few studies on the regulation of expression of Hfq-like proteins encoding genes are available, none of them implicating a sRNA. These studies on the regulation of hfq genes are restricted to Escherichia coli, to the intracellular pathogen Legionella pneumophila and to the legume symbiotic bacterium Sinorhizobium meliloti. In the case of E. coli, the hfq gene is part of an operon, being its transcription complex and under the control of several promoters [38]. In this bacterium, the rate of Hfq synthesis was found as maximal in cells in the exponential growth phase, and reduced in cells in the stationary phase, being the rate of synthesis under the control of cell growth rate [39]. It has been previously shown that the E. coli Hfq synthesis is autoregulated at the translational level, by a mechanism involving the binding of Hfq to 2 distinct sites of the 5′-UTR region of the hfq mRNA, inhibiting the formation of the translation initiation complex [40]. The S. meliloti Hfq protein was also shown to control its own expression at the translational level, both in its natural host, as well as in the heterologous host E. coli [41]. In the intracellular pathogen Legionella pneumophila, the hfq gene locates in a genome region only partially resembling that of E. coli. For this pathogen, a regulatory scheme was proposed in which the hfq expression is regulated during the exponential phase of growth by the sigma factor RpoS, while during the stationary phase the gene transcription is turned off, either directly or indirectly by the regulatory protein LetA, independently of RpoS [42]. Although much remains to be known on the regulation of hfq-like genes in the opportunistic pathogens of the Bcc, as well as from bacteria from other genera, it is quite expectable that the involvement of a sRNA in this regulation is restricted to members of Burkholderia genus, since no homologs to h2cR could be found outside the Burkholderia genus. In addition, 2 copies of hfq-like genes are present only among members of the B. genus, Bacillus anthracis, Magnetospirillum magnetotacticum and Novosphingobium aromaticivorans, and in the archaeal species Methanobacterium thermoautotrophicum and Archeoglobus fulgidus [43]. Work is in progress to gain further clues on the regulation of expression of the hfq and hfq2 genes, two important regulators of virulence and survival to stress conditions mimicking those faced by the opportunistic bacteria of the Bcc when infecting the cystic fibrosis host.
Funding Statement
This work was partially supported by Fundação Ciência e a Tecnologia, Portugal (contract PTDC/BIA-MIC/119091/2010), a Post-Doc grant to CGR and a research grant to JP da Costa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Gottesman S, McCullen CA, Guillier M, Vanderpool CK, Majdalani N, et al. (2006) Small RNA regulators and the bacterial response to stress. Cold Spring Harb Symp Quantitat Biol 71: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Wassarman KM (2002) Small RNAs in bacteria: Diverse regulators of gene Expression in response to environmental changes. Cell 109: 141–144. [DOI] [PubMed] [Google Scholar]
- 3. Bejerano-Sagie M, Xavier KB (2007) The role of small RNAs in quorum sensing. Curr Opin Microbiol 10: 189–198. [DOI] [PubMed] [Google Scholar]
- 4. Chao Y, Vogel J (2010) The role of Hfq in bacterial pathogens Curr Opin Microbiol. 13: 24–33. [DOI] [PubMed] [Google Scholar]
- 5.Gottesman S, Storz G (2011) Bacterial small RNA regulators: Versatile roles and rapidly evolving variations. Cold Spring Harb Perspect Biol. doi: 10.1101/cshperspect.a003798. [DOI] [PMC free article] [PubMed]
- 6. Liu JM, Camilli A (2010) A broadening world of bacterial small RNAs. Curr Opin Microbiol 13: 18–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Majdalani N, Vanderpool CK, Gottesman S (2005) Bacterial small RNA regulators. Critic Rev Biochem Mol Biol 40: 93–113. [DOI] [PubMed] [Google Scholar]
- 8. Papenfort K, Vogel J (2010) Regulatory RNA in bacterial pathogens. Cell Host Microbe 8: 116–127. [DOI] [PubMed] [Google Scholar]
- 9. Brantl S (2007) Regulatory mechanisms employed by cis-encoded antisense RNAs. Curr Opin Microbiol 10: 102–109. [DOI] [PubMed] [Google Scholar]
- 10. Møller T, Franch T, Højrup P, Keene DR, Bächinger HP, et al. (2002) Hfq: A bacterial Sm-like protein that mediates RNA-RNA interaction. Mol Cell 9: 23–30. [DOI] [PubMed] [Google Scholar]
- 11. Hwang W, Arluison V, Hohng S (2011) Dynamic competition of DsrA and rpoS fragments for the proximal binding site of Hfq as a means for efficient annealing. Nucleic Acids Res 39: 5131–5139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Updegrove T, Wilf N, Sun X, Wartell RM (2008) Effect of Hfq on RprA−rpoS mRNA Pairing: Hfq−RNA binding and the influence of the 5′ rpoS mRNA leader region. Biochemistry 47: 11184–11195. [DOI] [PubMed] [Google Scholar]
- 13. Soper TJ, Woodson SA (2008) The rpoS mRNA leader recruits Hfq to facilitate annealing with DsrA sRNA. RNA 14: 1907–1917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Bohn C, Rigoulay C, Bouloc P (2007) No detectable effect of RNA-binding protein Hfq absence in Staphylococcus aureus . BMC Microbiology 7: 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Veccerek B, Rajkowitsch L, Sonnleitner E, Schroeder R, Blasi U (2008) The C-terminal domain of Escherichia coli Hfq is required for regulation. Nucl Acids Res 36: 133–143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Beich-Frandsen M, Veccerek B, Konarev PV, Sjöblom Br, Kloiber K, et al. (2011) Structural insights into the dynamics and function of the C-terminus of the E. coli RNA chaperone Hfq. Nucleic Acids Res 39: 4900–4915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Olsen AS, Møller-Jensen J, Brennan RG, Valentin-Hansen P (2010) C-terminally truncated derivatives of Escherichia coli Hfq are proficient in riboregulation. J Mol Biol 404: 173–182. [DOI] [PubMed] [Google Scholar]
- 18. Rajkowitsch L, Schroeder R (2007) Dissecting RNA chaperone activity. RNA 13: 2053–2060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sousa SA, Ramos CG, Leitão JH (2011) Burkholderia cepacia complex: emerging multi-host pathogens equipped with a wide range of virulence factors and determinants. Int J Microbiol 2011, Article ID 6075751. [DOI] [PMC free article] [PubMed]
- 20. Ramos CG, Sousa SA, Grilo AM, Feliciano JR, Leitão JH (2011) The second RNA chaperone Hfq2, is also required for survival to stress and the full virulence of Burkholderia cenocepacia J2315. J Bacteriol 193: 1515–1526. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 21. Sousa SA, Ramos CG, Moreira LM, Leitão JH (2010) The hfq gene is required for stress resistance and full virulence of Burkholderia cepacia to the nematode Caenorhabditis elegans . Microbiology 156: 896–908. [DOI] [PubMed] [Google Scholar]
- 22. Sousa SA, Ramos CG, Almeida F, Meirinhos-Soares L, Wopperer J, et al. (2008) Burkholderia cenocepacia J2315 acyl carrier protein: a potential target for antimicrobials development? Microb Pathogen 45: 331–336. [DOI] [PubMed] [Google Scholar]
- 23. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406–3415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Rehmsmeier M, Steffen P, Höchsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10: 1507–1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Münch R, Hiller K, Grote A, Scheer M, Klein J, et al. (2005) Virtual Footprint and PRODORIC: an integrative framework for regulon prediction in prokaryotes. Bioinformatics 21: 4187–4189. [DOI] [PubMed] [Google Scholar]
- 26. Ramos CG, Sousa SA, Grilo AM, Eberl L, Leitão JH (2010) The Burkholderia cenocepacia K56-2 pleiotropic regulator Pbr, is required for stress resistance and virulence. Microb Pathogen 48: 168–177. [DOI] [PubMed] [Google Scholar]
- 27. Uehlinger S, Schwager S, Bernier SP, Riedel K, Nguyen DT, et al. (2009) Identification of Specific and Universal Virulence Factors in Burkholderia cenocepacia Strains by Using Multiple Infection Hosts. Infection and Immunity 77: 4102–4110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Marsh EK, May RC (2012) Caenorhabditis elegans, a Model Organism for Investigating Immunity. Applied and Environmental Microbiology 78: 2075–2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Coenye T, Drevinek P, Mahenthiralingam E, Shah SA, Gill RT, et al. (2007) Identification of putative noncoding RNA genes in the Burkholderia cenocepacia J2315 genome. FEMS Microbiol Lett 276: 83–92. [DOI] [PubMed] [Google Scholar]
- 30. Coenye T, Van Acker H, Peeters E, Sass A, Buroni S, et al. (2011) Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms. Antimicrob Agents Chemother 55: 1912–1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Peeters E, Sass A, Mahenthiralingam E, Nelis H, Coenye T (2010) Transcriptional response of Burkholderia cenocepacia J2315 sessile cells to treatments with high doses of hydrogen peroxide and sodium hypochlorite. BMC Genomics 11: 90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Roberts SA, Scott JR (2007) RivR and the small RNA RivX: the missing links between the CovR regulatory cascade and the Mga regulon. Mol Microbiol 66: 1506–1522. [DOI] [PubMed] [Google Scholar]
- 33. Folichon M, Arluison Vr, Pellegrini O, Huntzinger E, Règnier P, et al. (2003) The poly(A) binding protein Hfq protects RNA from RNase E and exoribonucleolytic degradation. Nucleic Acids Res 31: 7302–7310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Massé E, Escorcia FE, Gottesman S (2003) Coupled degradation of a small regulatory RNA and its mRNA targets in Escherichia coli. Genes Dev 17: 2374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Moll I, Afonyushkin T, Vytvytska O, Kaberdin VR, Blasi U (2003) Coincident Hfq binding and RNase E cleavage sites on mRNA and small regulatory RNAs. RNA 9: 1308–1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Markowitz VM, Chen IMA, Palaniappan K, Chu K, Szeto E, et al. (2010) The integrated microbial genomes system: an expanding comparative analysis resource. Nucleic Acids Res 30: D382–D390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Winsor GL, Khaira B, Van Rossum T, Lo R, Whiteside MD, et al. (2008) The Burkholderia Genome Database: facilitating flexible queries and comparative analyses. Bioinformatics 24: 2803–2804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Tsui HCT, Leung HCE, Winkler ME (1994) Characterization of broadly pleiotropic phenotypes caused by an hfq insertion mutation in Escherichia coli K 12. Mol Microbiol 13: 35–49. [DOI] [PubMed] [Google Scholar]
- 39. Kajitani M, Kato A, Wada A, Inokuchi Y, Ishihama A (1994) Regulation of the Escherichia coli hfq gene encoding the host factor for phage Q beta. J Bacteriol 176: 531–534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Vecerek B, Moll I, Blasi U (2005) Translational autocontrol of the Escherichia coli hfq RNA chaperone gene. RNA 11: 976–984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Sobrero P, Valverde C (2011) Evidences of autoregulation of hfq expression in Sinorhizobium meliloti strain 2011. Arch Microbiol 193: 629–639. [DOI] [PubMed] [Google Scholar]
- 42. McNealy TL, Forsbach-Birk V, Shi C, Marre R (2005) The Hfq homolog in Legionella pneumophila demonstrates regulation by LetA and RpoS and interacts with the global regulator CsrA. J Bacteriol 187: 1527–1532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Salgado-Garrido J, Bragado-Nilsson E, Kandels-Lewis S, Séraphin B (1999) Sm and Sm-like proteins assemble in two related complexes of deep evolutionary origin. EMBO J 18: 3451–3462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Vandamme P, Holmes B, Coenye T, Goris J, Mahenthiralingam E, et al. (2003) Burkholderia cenocepacia sp. nov.–a new twist to an old story. Res Microbiol 154: 91–96. [DOI] [PubMed] [Google Scholar]
- 45. Lefebre MD, Valvano MA (2002) Construction and evaluation of plasmid vectors optimized for constitutive and regulated gene expression in Burkholderia cepacia complex Isolates. Appl Environ Microbiol 68: 5956–5964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Kovach ME, Phillips RW, Elzer PH, Roop RM (1994) pBBR 1 MCS: a broad-host-range cloning vector. BioTechniques 16: 800–802. [PubMed] [Google Scholar]